CCI-779 (Temsirolimus) exhibits increased anti-tumor activity in low EGFR expressing HNSCC cell lines and is effective in cells with acquired resistance to cisplatin or cetuximab
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article (Journal) Book/Monograph |
| Language: | English |
| Published: |
London
BioMed Central
2015
|
| Online Access: | Resolving-System, kostenfrei, Volltext: http://nbn-resolving.de/urn:nbn:de:bsz:16-heidok-194230
|
| Author Notes: | Franziska Niehr; Wilko Weichert; Albrecht Stenzinger; Volker Budach; Ingeborg Tinhofer |
| Item Description: | Aus: Journal of Translational Medicine, 13 (2015), Nr. 106. pp. 1-13. ISSN 1479-5876 |
|---|---|
| Physical Description: | Online Resource |